Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Intralesional Injection of Hyaluronic Acid Compared With Verapamil in Peyronie's Disease: A Prospective Randomized Clinical Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05855070
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:10.817241+00:00
Published At
2023-05-11T00:00:00+00:00
Record Updated At
2023-05-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Peyronie\u0027s Disease", "Hyaluronic Acid", "Verapamil"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-11"
protocolSection.identificationModule.nctId
"NCT05855070"
protocolSection.identificationModule.officialTitle
"Intralesional Injection of Hyaluronic Acid Compared With Verapamil in Peyronie\u0027s Disease: A Prospective Randomized Clinical Trial"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Peyronie's Disease (protocolSection.conditionsModule.conditions)
  • Hyaluronic Acid (protocolSection.conditionsModule.conditions)
  • Verapamil (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.